Evaluation of the clinical efficacy of 5% topical amlexanox in comparison with 0.03% tacrolimus and 0.1% triamcinolone acetonide oromucosal paste in treatment of erosive oral lichen planus patients: A prospective, evaluative study

Abstract Introduction: Oral lichen planus is one of the most common mucocutaneous disorders affecting the skin and oral mucosa with a definite potential for malignant transformation. The aim of the present study was to evaluate the clinical efficacy of 5% topical amlexanox in comparison with 0.03% tacrolimus and 0.1% triamcinolone acetonide oromucosal paste in the treatment of erosive oral lichen planus patients. Materials and Methods: The present prospective, evaluative study included 90 patients who were diagnosed with erosive oral lichen planus. The selected patients were randomly assigned to one of the 3 treatment groups using a simple randomization method and were prescribed three different medications, whereas the drug efficacy and safety evaluations were performed every week for the next 3 weeks, and the data obtained were subjected to statistical analysis. Results: The findings of the present study suggested a significant reduction in Visual Analog Scale scores after 3 weeks of treatment in all 3 groups when compared from baseline to the end of 1 st , 2 nd , and 3 rd weeks of treatment ( P < 0.001), though, symptom relief was found to be maximum in case of patients who were prescribed 5% topical amlexanox oromucosal paste than as compared to the other two groups wherein the patients were prescribed 0.03% tacrolimus and 0.1% triamcinolone acetonide respectively. Conclusions: The present study observed that 5% topical amlexanox oromucosal paste was well-tolerated, which reportedly led to no distinct adverse effects as reported with tacrolimus and triamcinolone acetonide, making it a potentially useful therapeutic option for the treatment of erosive oral lichen planus patients. The following core competencies are addressed in this article: Practice-based learning and improvement, Patient care and procedural skills, Systems-based practice, and Medical knowledge.

Authors

Institutions

Publication Details

Journal
International Journal of Academic Medicine
Published
2026-07-01
DOI
https://doi.org/10.4103/ijam.ijam_47_25
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the clinical efficacy of 5% topical amlexanox in comparison with 0.03% tacrolimus and 0.1% triamcinolone acetonide oromucosal paste in treatment of erosive oral lichen planus patients: A prospective, evaluative study

Praveena Raman, Muhammad Salim Khan, Mohammed A. Albulowey, Abhishek Singh Nayyar et al.
International Journal of Academic Medicine
Oral Health Pathology and Treatment
article

Evaluation of the clinical efficacy of 5% topical amlexanox in comparison with 0.03% tacrolimus and 0.1% triamcinolone acetonide oromucosal paste in treatment of erosive oral lichen planus patients: A prospective, evaluative study

Praveena Raman, Muhammad Salim Khan, Mohammed A. Albulowey, Abhishek Singh Nayyar, Syed S. Hassan, C. Swarnalatha, Abdulsalam S. Alshammari, Suresh J. Babu, Abdullah S. AlRafee
article en

Abstract

Abstract Introduction: Oral lichen planus is one of the most common mucocutaneous disorders affecting the skin and oral mucosa with a definite potential for malignant transformation. The aim of the present study was to evaluate the clinical efficacy of 5% topical amlexanox in comparison with 0.03% tacrolimus and 0.1% triamcinolone acetonide oromucosal paste in the treatment of erosive oral lichen planus patients. Materials and Methods: The present prospective, evaluative study included 90 patients who were diagnosed with erosive oral lichen planus. The selected patients were randomly assigned to one of the 3 treatment groups using a simple randomization method and were prescribed three different medications, whereas the drug efficacy and safety evaluations were performed every week for the next 3 weeks, and the data obtained were subjected to statistical analysis. Results: The findings of the present study suggested a significant reduction in Visual Analog Scale scores after 3 weeks of treatment in all 3 groups when compared from baseline to the end of 1 st , 2 nd , and 3 rd weeks of treatment ( P < 0.001), though, symptom relief was found to be maximum in case of patients who were prescribed 5% topical amlexanox oromucosal paste than as compared to the other two groups wherein the patients were prescribed 0.03% tacrolimus and 0.1% triamcinolone acetonide respectively. Conclusions: The present study observed that 5% topical amlexanox oromucosal paste was well-tolerated, which reportedly led to no distinct adverse effects as reported with tacrolimus and triamcinolone acetonide, making it a potentially useful therapeutic option for the treatment of erosive oral lichen planus patients. The following core competencies are addressed in this article: Practice-based learning and improvement, Patient care and procedural skills, Systems-based practice, and Medical knowledge.

International Journal of Academic Medicine
King Fahd Medical City (SA), Tamil Nadu Government Dental College and Hospital (IN), University of Ha'il (SA), SRM Dental College (IN), Saraswati Dental College and Hospital (IN), Ragas Dental College & Hospital (IN), Jazan University (SA)
Quality Education
Openalex Percentile: Top 7%
Oral Health Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.